Product Description
Omalizumab is an FDA-approved drug used for the treatment of moderate-to-severe persistent asthma in adults and pediatric patients 6 or older who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are not adequately controlled with inhaled corticosteroids.